Please assess the completion status of the following clinical trial:

Trial Title: Implantation With the Nucleus CI532 Cochlear Implant in Adults

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Meet current cochlear implant criteria at the implanting center~* 18 years or older with bilateral sensorineural hearing loss~* Limited benefit from appropriate binaural hearing aids~* Moderate to profound hearing loss in the low frequencies and profound hearing loss in the mid to high frequencies~* Preoperative unaided threshold between 40 and 65 dB HL, inclusively, at 250 Hertz (Hz) and 500 Hz in the ear to be implanted~* Fluent speaker in the language used to assess clinical performance~Exclusion Criteria:~* Evidence of hearing loss prior to age 5~* Sensorineural severe to profound hearing loss greater than 20 years at and above 2000Hz~* Simultaneous bilateral implantation prior to the study~* Medical or psychological conditions that contraindicate undergoing general anesthesia or surgery~* Cochlear anomaly that might prevent complete insertion of the electrode array~* Hearing impairment due to lesion or neuropathy of the acoustic nerve, VIII nerve, or central auditory pathway~* Active middle ear infection~* Tympanic membrane perforation~* Unrealistic expectations~* Unwillingness or inability co comply with all investigational requirements~* Patients with existing cerebral shunts or drains~* Recurrent episodes of bacterial meningitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Surgical (Type: EXPERIMENTAL): Subjects to be implanted with the CI532 cochlear implant in one ear

Based on this trial design, predict the completion outcome and termination type (if applicable).